Cargando…

Virus replication and competition in a cell culture: Application to the SARS-CoV-2 variants

Viral replication in a cell culture is described by a delay reaction–diffusion system. It is shown that infection spreads in cell culture as a reaction–diffusion wave, for which the speed of propagation and viral load can be determined both analytically and numerically. Competition of two virus vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ait Mahiout, L., Mozokhina, A., Tokarev, A., Volpert, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155187/ https://www.ncbi.nlm.nih.gov/pubmed/35669092 http://dx.doi.org/10.1016/j.aml.2022.108217

Ejemplares similares

Competition of SARS-CoV-2 Variants in Cell Culture and Tissue: Wins the Fastest Viral Autowave
por: Tokarev, Alexey, et al.
Publicado: (2022)

The Influence of Immune Response on Spreading of Viral Infection
por: Ait Mahiout, L., et al.
Publicado: (2023)

Emergence and competition of virus variants in respiratory viral infections
por: Bessonov, Nikolai, et al.
Publicado: (2023)

Selective sweeps in SARS-CoV-2 variant competition
por: Boyle, Laura, et al.
Publicado: (2022)

Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M(pro), Impairing Variants Replication In Vitro and In Vivo
por: Chaves, Otávio Augusto, et al.
Publicado: (2021)

Competition of SARS-CoV-2 variants on the pandemic transmission dynamics
por: Chen, Jiaqi, et al.
Publicado: (2023)

Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
por: Mautner, Lena, et al.
Publicado: (2022)

Modelling of the Innate and Adaptive Immune Response to SARS Viral Infection, Cytokine Storm and Vaccination
por: Leon, Cristina, et al.
Publicado: (2023)

New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture
por: Sulimov, Alexey, et al.
Publicado: (2022)

Assessment of SARS-CoV-2 replication in the context of other respiratory viruses
por: Belser, Jessica A
Publicado: (2020)

Comparison of genome replication fidelity between SARS-CoV-2 and influenza A virus in cell culture
por: Kawasaki, Yoshiko, et al.
Publicado: (2023)

Methotrexate inhibits SARS‐CoV‐2 virus replication “in vitro”
por: Caruso, Arnaldo, et al.
Publicado: (2020)

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
por: Alhammad, Yousef M., et al.
Publicado: (2023)

Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host
por: Caccuri, Francesca, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 variants in primary human nasal cultures indicates Delta as most cytopathic and Omicron as fastest replicating
por: Tanneti, Nikhila S, et al.
Publicado: (2023)

The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry
por: Zhang, Junsong, et al.
Publicado: (2021)

The Anti-Influenza Virus Drug Favipiravir Has Little Effect on Replication of SARS-CoV-2 in Cultured Cells
por: Tomita, Yuriko, et al.
Publicado: (2021)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus
por: Havranek, Katherine Elizabeth, et al.
Publicado: (2020)

Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
por: Hui, Kenrie P.Y., et al.
Publicado: (2022)

SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
por: Vargas-Herrera, Natalia, et al.
Publicado: (2021)

siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication
por: Li, T, et al.
Publicado: (2005)

Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs
por: Jones, Les, et al.
Publicado: (2021)

Protein Kinase C Inhibitors Reduce SARS-CoV-2 Replication in Cultured Cells
por: Huang, Changbai, et al.
Publicado: (2022)

A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual
por: Caccuri, Francesca, et al.
Publicado: (2020)

SARS-CoV-2 variants reveal features critical for replication in primary human cells
por: Pohl, Marie O., et al.
Publicado: (2021)

Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin
por: Al-Beltagi, Sarah, et al.
Publicado: (2021)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2023)

The Cyclophilin-Dependent Calcineurin Inhibitor Voclosporin Inhibits SARS-CoV-2 Replication in Cell Culture
por: Ogando, Natacha S., et al.
Publicado: (2022)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
por: Mlcochova, Petra, et al.
Publicado: (2021)

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
por: Tripp, Ralph A., et al.
Publicado: (2022)

Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus
por: Vitner, Einat B., et al.
Publicado: (2021)

Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs
por: Boutin, Sébastien, et al.
Publicado: (2021)

Aprotinin Inhibits SARS-CoV-2 Replication
por: Bojkova, Denisa, et al.
Publicado: (2020)

Inhibition of SARS-CoV replication by siRNA
por: Wu, Chang-Jer, et al.
Publicado: (2005)

SARS-CoV-2 replicates in respiratory ex vivo organ cultures of domestic ruminant species
por: Di Teodoro, Giovanni, et al.
Publicado: (2021)

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
por: Nair, M.S., et al.
Publicado: (2021)

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
por: Nair, M.S., et al.
Publicado: (2021)

SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility
por: Zhou, Bin, et al.
Publicado: (2020)

Human Superantibodies to 3CL(pro) Inhibit Replication of SARS-CoV-2 across Variants
por: Glab-ampai, Kittirat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oi686hkq2f5rlr933nongk8c7u